Inactivated Pertussis Bacteria Antigen
-
产品编号
BAG1103
-
别名
灭活百日咳杆菌抗原, 百日咳杆菌, Inactivated Pertussis Bacteria, Inactivated Pertussis, Pertussis
-
规格
- 250ul
- 1ml
产品介绍
| Alias | 灭活百日咳杆菌抗原, 百日咳杆菌, Inactivated Pertussis Bacteria, Inactivated Pertussis, Pertussis |
| Catalog Number | BAG1103 |
| Molecular Name | Pertussis Bacteria |
| Species | Bacteria |
| Host | Pertussis Bacteria |
| Size | 250ul, 1ml |
| Purity | >95% |
| Purification | IEC & HPLC |
| Formulation | Powder or 0.1M PBS, PH 7.0 |
| Background | Pertussis (also known as whooping cough or 100-day cough) is a highly contagious bacterial disease. Initially, symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough. This is followed by weeks of severe coughing fits. |
| Application | Immunogen, WB, ELISA |
| Storage Condition | Store the lyophilized powder at 4℃ for 6 months. It is recommended to aliquote to ~10ul per vial and store at -20℃ for long term storage. Avoid repeated freezing and thawing cycles. |
FAQ
-
Q1-抗原是否包含百日咳全细胞成分或特定抗原（如PT、FHA）？
提供全细胞灭活抗原或纯化的单一组分（如百日咳毒素PT、丝状血凝素FHA），可定制组合。
-
Q2-如何保证抗原的免疫原性？
通过小鼠免疫实验测定抗体效价及中和活性，确保抗原诱导强效Th1/Th2免疫应答。
-
Q3-是否适用于无细胞百日咳疫苗（aP疫苗）开发？
是的，支持aP疫苗的抗原配方优化，包括PT、FHA、PRN等组分的比例调整。
-
Q4-批次间一致性如何控制？
每批次均通过蛋白浓度、内毒素检测及功能活性验证，确保差异≤10%。
-
Q5-是否提供抗原-佐剂复合体制备服务？
支持与铝佐剂、CpG等新型佐剂的复合体开发，并提供稳定性测试数据。
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
